A Phase 4 Clinical Study of Brodalumab

Clinical trial NCT04183881 · COMPLETED

Trial details

NCT number: NCT04183881
Sponsor: Kyowa Kirin Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Vulgaris Psoriatic Arthritis Pustular; Psoriasis, Palmaris Et Plantaris Psoriatic Erythroderma

Start date: 2016-07-04
Primary completion: 2017-01-10
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.